USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2023-11-09 обновлены отчеты компании NBSE: 2023-Q3 ∙ 2022-Q4 ∙ 2022-Q3
  1. Главная
  2. Котировки акций
  3. NeuBase Therapeutics
  4. Мультипликаторы
NeuBase Therapeutics logo
NeuBase Therapeutics NBSE
$ 0.44 -0.54%
mail-toСообщить о неточности

NeuBase Therapeutics Мультипликаторы 2011-2024 | NBSE

Мультипликаторы по годам NeuBase Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 - -1.1 -8.8 -1.6 -0.9 -1.1 -3.8 -5.5 -17.4 -23.8 -46.7 -4.9

P/S

 - -121.6 - - - - - - - - - -

EPS

 -1.0 -0.9 -0.9 -3.3 -0.2 -0.5 -0.8 -0.5 -0.4 -0.3 -0.0 -0.1

EV (Enterprise Value)

 -13.7 млн -15.5 млн 125 млн 35 млн 12.3 млн 19.6 млн 89.1 млн 58.4 млн 151 млн 130 млн 66.4 млн 30.9 млн

EBITDA per Share

 -1 -0.96 -0.856 -3.17 -2.82 -10.1 -15.4 -11.5 -7.82 -4.84 -4.49 -1.8

EV/EBITDA

 0.6 -7.3 -1.2 -1.0 -0.6 -3.5 -3.4 -16.8 -28.6 -20.4 -21.3

PEG

 - 0.03 -0.12 -0.05 -0.02 -0.03 0.07 0.17 0.47 0.1 -0.61 0.01

P/B

 - 0.5 4.9 4.3 1.1 1.2 3.9 2.0 5.9 25.6 28.0 -5.3

P/CF

 - -1.4 -13.5 -12.6 -1.2 -1.4 -6.1 -7.7 -17.9 -50.0 -38.0 -25.0

ROE %

 -145.64 -46.99 -55.55 -268.79 -121.43 -104.23 -103.22 -35.77 -34.13 -107.38 -59.96 106.69

ROA %

 -103.31 -39.60 -50.47 -215.13 -113.85 -85.26 -87.51 -32.77 -28.51 -98.41 -41.36 -361.08

ROCE %

 -143.66 -49.13 -54.54 -262.59 -83.28 -103.72 -101.37 -41.11 -34.10 -87.78 -135.45 26.00

Current Ratio

 3.4 6.4 10.4 4.4 5.5 2.6 3.0 7.5 2.5 10.8 2.6 0.1

DSO

 - - - - - - - - - - - -

DIO

 - - - - - - - - - - - -

DPO

 - - - - - - - - - - - -

Операционный цикл

 - - - - - - - - - - - -

Финансовый цикл

 - - - - - - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально NeuBase Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 -0.66 -2.04 -0.12 -0.13 -4.73 -5.26 -0.3 -0.24 -0.72 -0.29 -0.24 -0.18 -0.69 -0.18 -0.26 -0.26 -0.96 -0.38 -0.26 -0.25 -3.36 -0.19 -0.32 -1.48 -0.45 -0.07 -0.07 -0.21 -0.21 -0.24 -0.21 -0.2 -0.13 -0.11 -0.2 -0.18 -0.12 -0.09 -0.18 -0.1 -0.07 -0.07 -0.1 -0.14 -0.11 -0.03 -0.05 0.01 -0.1 -0.08 -

EBITDA per Share

 -0.98 -2.06 -0.12 -2.66 -4.66 -5.06 -0.3 -0.22 -0.75 -0.29 -0.25 -0.2 -0.64 -0.17 -0.27 -0.21 -0.93 -0.34 -0.21 -0.25 -3.27 -0.31 -0.26 -1.39 -0.43 -0.07 -0.07 -0.2 -0.18 -0.23 -0.2 -0.11 -0.08 -0.1 -0.11 -0.15 -0.14 -0.08 -0.15 -0.1 -0.11 -0.07 -0.1 -0.02 -0.15 -0.04 -0.02 -0.01 -0.02 -0.01 -0.01

ROE %

 -102.88 -115.86 -113.23 -110.90 -103.32 -104.17 -90.53 -87.59 -85.45 -92.23 -91.18 -82.37 -132.22 -147.06 -162.68 -212.53 230.81 277.27 297.31 352.51 -47.81 -120.18 -128.35 -140.53 -146.43 -91.74 -105.51 -112.37 -101.18 -83.80 -60.83 -47.35 -51.63 -53.97 -53.77 -56.49 -83.00 -105.72 -123.47 -144.69 -508.73 -537.21 -530.78 -583.80 -183.33 -42.30 42.30 126.40 78.28 65.62 -7.33

ROA %

 -61.36 -74.93 -80.73 -81.99 -78.46 -83.56 -74.82 -63.09 -62.76 -71.15 -69.68 -72.88 -105.28 -112.76 -117.97 -142.12 -1181.48 -1496.80 -1488.28 -1460.74 -393.47 -100.32 -106.57 -113.03 -118.77 -74.83 -87.02 -95.84 -86.30 -72.19 -53.26 -42.82 -44.36 -45.57 -44.76 -45.86 -74.47 -96.22 -113.12 -133.96 -165.77 -177.65 -167.45 -195.31 -102.53 -324.19 -533.17 -445.28 -264.94 -222.07 24.82

ROCE %

 -50.49 -83.79 -86.13 -112.15 -102.40 -104.97 -92.05 -90.66 -91.51 -93.86 -92.61 -84.32 -121.80 -137.23 -151.72 -189.19 240.14 220.85 237.17 281.99 -114.76 -122.89 -128.20 -140.45 -146.20 -92.40 -105.96 -112.66 -94.90 -75.76 -53.17 -33.68 -43.05 -46.41 -46.24 -52.46 -80.45 -103.19 -120.87 -144.60 -248.83 -298.65 -299.43 -294.61 -129.39 -27.19 -378.20 -334.22 18.15 -377.17 10.40

Current Ratio

 2.0 2.0 3.1 3.5 3.4 4.1 4.6 5.8 6.3 7.7 6.3 13.7 10.9 10.9 10.9 3.5 5.0 5.0 5.0 0.3 0.9 16.0 17.9 6.2 5.5 5.5 5.5 7.7 6.6 6.6 6.6 8.4 11.9 11.9 11.9 4.3 6.1 6.1 6.1 18.3 12.0 12.0 12.0 1.2 3.2 3.2 3.2 0.4 0.2 0.2 0.2

DSO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD